News Search Results
Feb 05, 2026, 08:00 ET Sun Pharma Introduces SUNday, Highlighting the Everyday Realities of Skin Cancer Care
company in the U.S. as well as Global Emerging Markets. Sun's high growth Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
Feb 04, 2026, 10:00 ET Dr. Nathaniel Nataneli Joins OCLI Vision as Cornea Specialist
Medicine and JAMA Ophthalmology, and has authored multiple book chapters on topics ranging from dry eye disease to corneal endotheliitis.Dr. Nataneli is a Diplomate of the American Board of Ophthalmology and an active member of the American Academy of Ophthalmology and the American Society
More news about: OCLI Vision
Feb 04, 2026, 09:06 ET Sectra continues to have the world's happiest customers--wins Best in KLAS Awards in North America, Europe, Middle East/Africa, and Oceania
is an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for pathology, cardiology, orthopedics, ophthalmology, and genomics in one single system.To read the US and global reports, visit:
More news about: Sectra
Feb 04, 2026, 09:00 ET SECTRA CONTINUES TO HAVE THE WORLD'S HAPPIEST CUSTOMERS--WINS BEST IN KLAS AWARDS IN NORTH AMERICA, EUROPE, MIDDLE EAST/AFRICA, AND OCEANIA
module is an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for pathology, cardiology, orthopedics, ophthalmology, and genomics in one single system.To read the US and global reports, visit:
More news about: Sectra
Feb 03, 2026, 13:02 ET Beverly Hills Oculoplastic Surgeon Dr. Kami Parsa Launches Mendora, a new skincare ecosystem offering a science-backed approach to skin wellness
Clinical Professor at USC's Department of Ophthalmology and Department of Plastic Surgery, Dr. Parsa has published extensively in medical literature and lectures internationally on advances in periocular rejuvenation. He is a member of the American Academy of Ophthalmology and fellowship trained by the American
More news about: Mendora
Feb 03, 2026, 08:00 ET InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Investor
More news about: InMode Ltd.
Feb 03, 2026, 08:00 ET ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
drug modalities.Roee Farber, MD, CEO of ZipBio, said: "MeiraGTx's expertise in development of best-in-class genetic medicines in ophthalmology makes them the ideal partner to bring our next generation AI-designed Geographic Atrophy therapies to patients with a significant unmet need. This
More news about: ZipBio
Feb 02, 2026, 18:00 ET ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization
from Shanghai Jing'an District Shibei Hospital.The ZEISS ARTEVO 850 is a 3D-enabled digital microscope designed for multiple specialties in ophthalmology, setting the pace in digital visualization. It combines the proven benefits of a digital ophthalmic microscope with customizable 3D digital visualization,
More news about: Carl Zeiss Meditec AG
Feb 02, 2026, 18:00 ET ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization
from Shanghai Jing'an District Shibei Hospital.The ZEISS ARTEVO 850 is a 3D-enabled digital microscope designed for multiple specialties in ophthalmology, setting the pace in digital visualization. It combines the proven benefits of a digital ophthalmic microscope with customizable 3D digital visualization,
More news about: Carl Zeiss Meditec AG
Feb 02, 2026, 11:07 ET Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Feb 02, 2026, 11:00 ET Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Feb 02, 2026, 07:00 ET Vision Innovation Partners Acquires Ophthalmic Associates of Alexandria
acquired Ophthalmic Associates of Alexandria, a comprehensive ophthalmology practice in downtown Alexandria, Virginia. This acquisition marks VIP's 27th add-on since its founding in 2017 and complements its growing network of ophthalmology practices. Ophthalmic Associates of Alexandria, founded
More news about: Vision Innovation Partners
Feb 02, 2026, 07:00 ET InMode Responds to Transaction Rumors
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Forward-Looking
More news about: InMode Ltd.
Feb 01, 2026, 21:00 ET SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics
diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia,
More news about: SBC Medical Group Holdings Incorporated
Jan 29, 2026, 09:06 ET New President at ZEISS Industrial Quality Solutions USA to Lead Next Chapter of Growth and Transformation
assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture
More news about: Carl Zeiss Industrial Quality Solutions, LLC
Jan 29, 2026, 00:46 ET Piramal Pharma Limited Announces Results for Q3 and 9M FY26
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Limited
Jan 29, 2026, 00:35 ET Piramal Pharma Limited Announces Results for Q3 and 9M FY26
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Limited
Jan 28, 2026, 09:30 ET AEYE Health Expands Epic Integration for Portable Fully-Autonomous AI Eye Screening Across the US Healthcare System
results are automatically returned to the patient's medical record within seconds. When signs of disease are detected, an automated alert is sent to ophthalmology for timely follow-up. The entire process - from order to results - takes less than one minute. Full automation of reimbursement code billing and
More news about: AEYE Health
Jan 28, 2026, 06:08 ET Stellular Bio Announces Closing of Series 1 Financing
Allam, I.Y., Delta Journal of Ophthalmology 2021, 22:251–258;
More news about: Stellular Bio
Jan 27, 2026, 21:00 ET Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology
The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the same field among all institutes, globally.SINGAPORE, Jan. 27, 2026 /PRNewswire/ -- The Singapore
More news about: Singapore National Eye Centre; Singapore Eye Research Institute
Jan 27, 2026, 09:30 ET February is Age-related Macular Degeneration (AMD) and Low Vision Month at Prevent Blindness, Designed to Provide Helpful Sight-saving Resources and Support Programs
Age-related Macular Degeneration (AMD) and Low Vision," featuring W. Lloyd Clark, MD, Palmetto Retinal Center, and Assistant Clinical Professor of Ophthalmology at the University of South Carolina School of Medicine."
More news about: Prevent Blindness
Jan 27, 2026, 09:00 ET BTL Reports Global Revenue Exceeding $850 Million and Signals Accelerating Growth in North America for 2026
its 2026 initiatives, BTL announced that it has received regulatory clearance in Canada for its dry eye treatment solution, marking entry into ophthalmology as a new specialty segment within the North American market. In parallel, 2026 also marks the commercial launch of EMVITAL, a new functional laser
More news about: BTL
Jan 27, 2026, 08:29 ET /C O R R E C T I O N -- Orasis Pharmaceuticals/
triggered statistically significant movement of the ciliary muscle at near,1" said Florence Cabot, MD, Assistant Professor of Clinical Ophthalmology, Bascom Palmer Eye Institute, Miami, FL. "These findings are very encouraging, supporting that pilocarpine 0.4% is pupil selective and behaves
More news about: Orasis Pharmaceuticals
Jan 26, 2026, 12:54 ET Cincinnati Blepharoplasty Specialist Dr. Ginger Henson of AestheticEye Named 2026 Castle Connolly Top Doctor
over 15 years of experience. She is a graduate of Miami University and the University of Cincinnati College of Medicine. Dr. Henson completed her ophthalmology residency at the renowned Bascom Palmer Eye Institute in Miami, Florida, and further honed her expertise during a fellowship in Ophthalmic Plastic
More news about: AestheticEye Oculoplastic Surgeons
Jan 26, 2026, 10:01 ET Biomaterials Market worth $68.93 billion by 2030 | MarketsandMarkets™
is segmented by application into orthopedic, cardiovascular, dental, plastic surgery, urinary applications, wound healing, tissue engineering, ophthalmology, neurological/central nervous system, and other applications. In 2024, the orthopedic segment claimed the largest share of the global biomaterials
More news about: MarketsandMarkets